Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.08% |
| 2 | Financials | 6.03% |
| 3 | Industrials | 5.01% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Healthcare | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
IBM
IBM
$209B
| $242M | 0.15% |
1,651,541
+1,500,030
| +990% | +$218M |
|
|
AABA
102
DELISTED
Altaba Inc
AABA
| $240M | 0.15% |
3,439,600
-499,586
| -13% | -$34.8M |
|
103
JPMorgan Chase
JPM
$933B
| $240M | 0.15% |
2,245,888
+1,993,049
| +788% | +$202M |
|
104
Automatic Data Processing
ADP
$105B
| $240M | 0.15% |
2,046,570
+1,565,940
| +326% | +$179M |
|
|
ALXN
105
DELISTED
Alexion Pharmaceuticals
ALXN
| $238M | 0.14% |
1,986,216
+1,254,689
| +172% | +$153M |
|
106
CALL
Netflix
NFLX
$305B
| $236M | 0.14% |
12,292,000
-2,345,000
| -16% | -$45.2M |
|
107
PUT
Intuitive Surgical
ISRG
$126B
| $236M | 0.14% |
1,938,300
-177,600
| -8% | -$22.2M |
|
108
Walt Disney
DIS
$167B
| $233M | 0.14% |
+2,167,041
| New | +$223M |
|
109
CALL
Microsoft
MSFT
$3.35T
| $231M | 0.14% |
2,698,200
-1,471,700
| -35% | -$121M |
|
|
LLL
110
DELISTED
L3 Technologies, Inc.
LLL
| $230M | 0.14% |
1,163,742
+107,122
| +10% | +$20.4M |
|
111
XPO
XPO
$23.4B
| $228M | 0.14% |
7,203,307
+2,031,956
| +39% | +$52M |
|
112
CVS Health
CVS
$134B
| $227M | 0.14% |
3,130,062
+2,794,481
| +833% | +$203M |
|
113
PUT
Costco
COST
$423B
| $226M | 0.14% |
1,213,000
-58,700
| -5% | -$10.1M |
|
114
lululemon athletica
LULU
$13.6B
| $225M | 0.14% |
2,856,700
+50,631
| +2% | +$3.38M |
|
|
MON
115
DELISTED
Monsanto Co
MON
| $223M | 0.14% |
1,907,902
+994,392
| +109% | +$118M |
|
116
Berkshire Hathaway Class B
BRK.B
$1.1T
| $221M | 0.13% |
1,112,752
+991,564
| +818% | +$188M |
|
117
Mondelez International
MDLZ
$80.5B
| $220M | 0.13% |
5,151,287
+865,006
| +20% | +$36.3M |
|
118
Emerson Electric
EMR
$83.3B
| $220M | 0.13% |
3,149,949
+3,052,545
| +3,134% | +$198M |
|
119
PepsiCo
PEP
$191B
| $219M | 0.13% |
1,823,168
+1,732,425
| +1,909% | +$198M |
|
120
CALL
Chipotle Mexican Grill
CMG
$49.4B
| $217M | 0.13% |
37,480,000
+3,820,000
| +11% | +$22.8M |
|
121
Middleby
MIDD
$6.03B
| $214M | 0.13% |
1,588,485
+906,045
| +133% | +$111M |
|
122
Wells Fargo
WFC
$258B
| $213M | 0.13% |
3,513,670
+3,073,191
| +698% | +$174M |
|
123
CALL
Broadcom
AVGO
$1.85T
| $210M | 0.13% |
8,192,000
-377,000
| -4% | -$9.8M |
|
124
Burlington
BURL
$23.4B
| $210M | 0.13% |
1,703,271
+127,961
| +8% | +$13M |
|
125
Bunge Global
BG
$20.4B
| $209M | 0.13% |
3,120,660
+1,545,446
| +98% | +$105M |
|
Similar funds
Citadel Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Citadel Advisors opened 1,440 new positions and closed 989 in Q4 2017.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.